Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 10, 2008
The Translational Research Working Group developmental pathways: introduction and overviewErnest T Hawk, Lynn M Matrisian, William G Nelson, et al.
Cancer Metastasis Reviews|August 17, 2018
Bioactive lipid metabolism in platelet "first responder" and cancer biologyPreeti Kanikarla-Marie, Scott Kopetz, Ernest T Hawk, et al.
Cancer Biomarkers : Section a of Disease Markers|April 2, 2025
Multi-cancer early detection tests: Attributes for clinical implementationJon O Ebbert, Ernest T Hawk, Christopher V Chambers, et al.
Open Heart|July 5, 2017
Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographicJennifer S Davis, Hwa Young Lee, Jihye Kim, et al.
Gastroenterology|February 24, 2009
Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenomaAndrew T Chan, Ann G Zauber, Meier Hsu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 24, 2010
Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysisJian Gu, Jaffer A Ajani, Ernest T Hawk, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 29, 2010
Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention ResearchAbenaa M Brewster, Sherri L Patterson, Michele R Forman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 13, 2004
Irreversible ototoxicity associated with difluoromethylornithineChristopher D Lao, Patricia Backoff, Lawrence I Shotland, et al.
Clinical Therapeutics|March 6, 2012
The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placeboNadir Arber, David Lieberman, Timothy C Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 9, 2004
Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patientsFrank A Sinicrope, Elizabeth Half, Jeffrey S Morris, et al.
Pageof 9